Celularity
CELU
38 hedge funds and large institutions have $4.76M invested in Celularity in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
22% more call options, than puts
Call options by funds: $82K | Put options by funds: $67K
12% more funds holding
Funds holding: 34 → 38 (+4)
11% more capital invested
Capital invested by funds: $4.27M → $4.76M (+$488K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
0.48% less ownership
Funds ownership: 9.09% → 8.62% (-0.48%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$494K |
| 2 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
+$113K |
| 3 |
Renaissance Technologies
New York
|
+$83.4K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$73.9K |
| 5 |
GLF
Groupe la Francaise
Paris,
France
|
+$47.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YAG
Yorkville Advisors Global
Mountainside,
New Jersey
|
-$280K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$70.5K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$63K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$42K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$42K |
CELU Hedge Fund Activity: Q3 2025 in Review
38 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q3 2025, worth a combined $4.76M — up 11% from $4.27M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CELU positions and 4 closed out — a net gain of 4 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Vanguard Group, adding an estimated $494K. The largest seller was Yorkville Advisors Global, cutting an estimated $280K.
- 38 institutional investors held Celularity (CELU) as of Q3 2025, up from 34 in Q2 2025.
- Funds reported $4.76M of Celularity stock for Q3 2025, up 11% quarter-over-quarter.
- 8 funds opened new Celularity positions in Q3 2025 and 4 closed out, a net change of +4 holders.
- The largest Celularity buyer in Q3 2025 was Vanguard Group, an estimated $494K added.
- The largest Celularity seller in Q3 2025 was Yorkville Advisors Global, an estimated $280K sold.
Based on aggregated 13F filings for Q3 2025.